ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 102 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q2 2018. The put-call ratio across all filers is 0.27 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $125,000 | -41.3% | 57,768 | -5.0% | 0.06% | -37.5% |
| Q2 2021 | $213,000 | +0.9% | 60,785 | +183.5% | 0.09% | -1.1% |
| Q1 2021 | $211,000 | -7.5% | 21,443 | +1.8% | 0.09% | -6.3% |
| Q4 2020 | $228,000 | +53.0% | 21,057 | +45.7% | 0.10% | +21.8% |
| Q3 2020 | $149,000 | -56.6% | 14,457 | -12.0% | 0.08% | -51.9% |
| Q2 2020 | $343,000 | +3.0% | 16,434 | -51.8% | 0.16% | +18.2% |
| Q1 2020 | $333,000 | -26.0% | 34,113 | -12.7% | 0.14% | +85.1% |
| Q4 2019 | $450,000 | +254.3% | 39,082 | +67.4% | 0.07% | +184.6% |
| Q3 2019 | $127,000 | -56.7% | 23,351 | -5.3% | 0.03% | -58.1% |
| Q2 2019 | $293,000 | -41.6% | 24,652 | -70.3% | 0.06% | +19.2% |
| Q3 2018 | $502,000 | -34.2% | 82,998 | -42.3% | 0.05% | -92.3% |
| Q2 2018 | $763,000 | – | 143,951 | – | 0.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 4,112,355 | $40,178,000 | 34.81% |
| Versant Venture Management, LLC | 7,068,233 | $69,056,636,000 | 18.94% |
| ACUTA CAPITAL PARTNERS, LLC | 1,704,500 | $16,653,000 | 8.07% |
| Soleus Capital Management, L.P. | 313,900 | $3,067,000 | 3.57% |
| Ghost Tree Capital, LLC | 1,305,500 | $12,755,000 | 3.38% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 480,000 | $4,690,000 | 2.97% |
| RTW INVESTMENTS, LP | 6,631,627 | $64,791,000 | 2.79% |
| VR Adviser, LLC | 994,381 | $9,715,000 | 2.63% |
| Avoro Capital Advisors LLC | 7,150,000 | $69,856,000 | 2.36% |
| RA Capital Management | 7,272,714 | $71,054,000 | 2.24% |